| 12251423 |
Method of effecting neuroprotection using soluble neuregulin isoforms |
— |
2025-03-18 |
| 10813978 |
Method of effecting neuroprotection using soluble neuregulin isoforms |
— |
2020-10-27 |
| 10350269 |
Method of effecting neuroprotection using soluble Neuregulin isoforms |
— |
2019-07-16 |
| 8546086 |
Use of neuregulin-β as an indicator and/or target |
— |
2013-10-01 |
| 8466144 |
Muscarinic antagonists with parp and sir modulating activity as cytoprotective agents |
— |
2013-06-18 |
| 8409812 |
Annexin A3 for cancer diagnosis |
Michael Cahill |
2013-04-02 |
| 8377648 |
Autoimmune regulation of prostate cancer by annexin A3 |
— |
2013-02-19 |
| 8039464 |
Muscarinic antagonists with PARP and SIR modulating activity as agents for inflammatory diseases |
— |
2011-10-18 |
| 8012697 |
Monoclonal anti-annexin A3 antibodies for the detection of prostate carcinoma |
— |
2011-09-06 |
| 7998970 |
Use of finasteride, dutasteride and related compounds for the prevention or treatment of neurologically-associated disorders |
Vukic Soskic |
2011-08-16 |
| 7919582 |
Neuregulin-β isoform |
— |
2011-04-05 |
| 7824923 |
Neuregulin-β isoforms associated with neuronal processes |
— |
2010-11-02 |
| 7759068 |
Use of substances for treating tumors |
Michael Cahill, Wojciech Wozny, Helmut Klocker, Hermann Rogatsch |
2010-07-20 |
| 7732148 |
Annexin A3 for prostate cancer diagnosis |
Michael Cahill |
2010-06-08 |
| 7538197 |
Use of neuregulin-β as an indicator and/or target |
— |
2009-05-26 |